On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridaySep 25, 2020 2:41 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Advancing Lead Program, Plans Additional Clinical Trials

180 Life Sciences, a clinical-stage biotechnology company, is dedicated to producing solutions designed to battle inflammation when the body’s natural processes go awry. The company’s primary focus is to treat fibrosis and inflammation using anti-TNF therapy, designed to block the activity of TNF, a substance in the body that can cause inflammation and lead to immune-system diseases. The company is advancing on this front as discussed by a recent article that reads, “180 Life Sciences’ lead program is in phase 2b/3 clinical trials and expects to deliver its first results next year. Other clinical trials planned by the company are…

Continue Reading

FridaySep 25, 2020 2:18 pm

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Sequire Provides Key Insight for Public Company Execs

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology products, gives public companies an edge with critical data to successfully activate media campaigns, engage shareholders and attract investment. The company’s data analytics platform – Sequire – has proven a key tool for decision makers in the public realm, recently doubling its user base to amass over 1 million active investors and traders. A recent article discussing this quotes SRAX founder and CEO Christopher Miglino, who states, “We are creating a community of public company executives that are taking back their data. For too long these leaders have relied…

Continue Reading

FridaySep 25, 2020 2:07 pm

QualityStocksNewsBreaks – Cybin Corp. Leverages Two-Pronged Approach to Target Psychedelic, Nutraceutical Sectors

Cybin Corp., a Canada-based life-science company, looks to benefit from its growing footprint in two billion-dollar markets: nutraceuticals and psychedelic drugs. Both sectors are projected to see significant growth in the coming years. The global nutraceutical market was valued at $382.51 billion in 2019 and is expected to grow at an 8.3% compound annual growth rate (“CAGR”) over the next seven years. Meanwhile, the psychedelic drugs market is projected to reach $6.85 billion by 2027. Cybin’s business model is structured around two wholly owned divisions focused on targeting both promising spaces. A recent article discussing this reads, “Cybin is committed…

Continue Reading

FridaySep 25, 2020 1:48 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Spotlight on Dynamic Platform Capabilities

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, recently had the opportunity to showcase its growing medical technology accomplishments at multiple virtual investor conferences. Trxade Group CEO Suren Ajjarapu took the company’s message well beyond physical borders to virtual summits in the month of September, providing insight into the dynamic capabilities and expansion of the Trxade Exchange platform. A recent article discussing this reads, “Trxade Group has been building its B2B platform into a B2C-friendly portfolio that helps independent local pharmacies compete with large-scale retail chains through drug pricing transparency and network strength. The platform also assists health…

Continue Reading

FridaySep 25, 2020 11:58 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Pricing of $12.6M US IPO

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) (FRA: WK3D) (NASDAQ: SYTA, SYTAW), a B2B global vendor of next-generation cellular solutions, today announced the pricing of its U.S. initial public offering (“IPO”) of 2,100,000 units at a price of US$6.00 per unit. According to the update, each unit consists of one common share and one warrant to purchase one common share. The common shares and warrants are immediately separable from the units and will be issued separately. Approved to list on the Nasdaq Capital Market, the common shares and warrants commenced trading on September 25, 2020, under the symbols “SYTA” and “SYTAW.”…

Continue Reading

FridaySep 25, 2020 11:27 am

QualityStocksNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Participates in Gravitas Clean Technology Investor Day, Announces Strategic Collaboration

Exro Technologies (CSE: XRO) (OTCQB: EXROF), a leading technology company that has developed a new class of power electronics for powertrains, recently announced its participation in the Gravitas Clean Technology Investor Day. According to the update, Exro CEO Sue Ozdemir presented at the event, which took place virtually on September 24, 2020, sharing the company’s growth strategy and fielding questions from investors. In addition, the company on Thursday announced its collaboration with Heinzmann GMBH & Co. KG to integrate Exro's patented coil drive technology into micro mobility applications. Heinzmann is a renowned manufacturer of electric drives up to 30 kW…

Continue Reading

FridaySep 25, 2020 10:50 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces AGM Results

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced voting results of its annual general and special meeting of shareholders (“AGM”). According to the update, shareholders voted in favor of each of the presented items of business, including the election of the director nominees listed in the company's management information circular. This included the election of Garth Hankinson, who currently serves as executive VP and CFO of Constellation Brands Inc., to the Canopy Rivers Board of Directors. John Bell, the board’s former chair, did not seek re-election at the meeting. "We thank John…

Continue Reading

FridaySep 25, 2020 10:24 am

QualityStocksNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Q4 and Full-Year 2020 Results

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of distinct businesses, products and brands, on Thursday announced financial results for the fourth quarter and full-year 2020. According to the update, the company established a platform for strong revenue growth and operational efficiency with a strengthened balance sheet. "Fiscal 2020 was an important transitional year for Supreme Cannabis where we streamlined our operations, reorganized our team, and expanded our portfolio of brands and products that will drive sustainable revenue growth," said Supreme Cannabis president and CEO Beena Goldenberg in the press release. "Looking into 2021, we…

Continue Reading

FridaySep 25, 2020 9:53 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expanding A88CBD(TM) Line with Highly Anticipated Ingestible and Topical Products

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Thursday announced that it will introduce new A88CBD(TM) infused ingestible and topical products for its lifestyle brand at A88CBD.com and select retail outlets. According to the update, the new products will be available in October 2020. “We are excited to announce our much-awaited A88CBD line of gummies available in four exciting flavors. Also, we strengthened our water portfolio with a new Lemon-Lime CBD flavored water and our A88CBD topicals portfolio with a deep-relief cream and bath bombs,” said…

Continue Reading

ThursdaySep 24, 2020 3:50 pm

QualityStocksNewsBreaks – Pure Extract Technologies Inc. Eyes Functional Mushroom Sector for Initial Product Lines

Pure Extract Technologies, a private, plant-based extraction company poised to enter the commercial cannabis sector with a new vertical in functional mushrooms, has seized the opportunity to reveal its business development strategy (https://ibn.fm/6OXiR). A recent article discussing this reads, “As Pure Extracts positions itself to become the premier commercialization and manufacturing partner for functional companies going forward, the company plans to center its initial product lines on functional mushroom products. In its bid to do so, the company is applying for a Natural Health Products site license with Health Canada, which, once received, will enable Pure Extracts to begin producing clinical…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered